LECAP Asset Management’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-5,352
Closed -$644K 340
2026
Q1
$644K Buy
+5,352
New +$618K 0.24% 164
2025
Q4
Sell
-17,741
Closed -$1.49M 354
2025
Q3
$1.49M Buy
17,741
+167
+1% +$13.8K 0.52% 66
2025
Q2
$1.39M Sell
17,574
-6,278
-26% -$499K 0.49% 66
2025
Q1
$2.14M Buy
23,852
+5,415
+29% +$506K 0.5% 74
2024
Q4
$1.83M Sell
18,437
-2,392
-11% -$247K 0.5% 70
2024
Q3
$2.37M Buy
20,829
+4,142
+25% +$492K 0.51% 62
2024
Q2
$2.07M Buy
16,687
+9,137
+121% +$1.18M 0.45% 78
2024
Q1
$996K Buy
7,550
+4,508
+148% +$556K 0.21% 176
2023
Q4
$332K Buy
+3,042
New +$316K 0.12% 245

Other funds holding MRK

LECAP Asset Management's MRK Position: Q2 2026 in Review

LECAP Asset Management sold out of Merck (MRK) in Q2 2026, closing a stake of 5,352 shares — an estimated $644K sold.

LECAP Asset Management first reported a position in MRK in Q4 2023 and held it in 9 quarters. The position peaked at $2.37M in Q3 2024. 3,824 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • LECAP Asset Management reported no remaining Merck position as of Q2 2026 after selling out during the quarter.
  • LECAP Asset Management sold 5,352 Merck shares in Q2 2026, an estimated $644K.
  • LECAP Asset Management first reported a position in Merck in Q4 2023 and held it in 9 quarters.
  • LECAP Asset Management's Merck position peaked at $2.37M in Q3 2024.
  • 3,824 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on LECAP Asset Management's 13F filing for Q2 2026, filed 30 Jul 2026.